189 related articles for article (PubMed ID: 37822663)
21. Inhibitors of ectonucleotidases have paradoxical effects on synaptic transmission in the mouse cortex.
Gleizes M; Fonta C; Nowak LG
J Neurochem; 2022 Feb; 160(3):305-324. PubMed ID: 34905223
[TBL] [Abstract][Full Text] [Related]
22. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Lamie PF; Ali WAM; Bazgier V; Rárová L
Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
[TBL] [Abstract][Full Text] [Related]
23. Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases.
Andleeb H; Hameed S; Ejaz SA; Khan I; Zaib S; Lecka J; Sévigny J; Iqbal J
Bioorg Chem; 2019 Jul; 88():102893. PubMed ID: 30986550
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents.
Ji Q; Yang D; Wang X; Chen C; Deng Q; Ge Z; Yuan L; Yang X; Liao F
Bioorg Med Chem; 2014 Jul; 22(13):3405-13. PubMed ID: 24856180
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis,
Aziz NAAM; George RF; El-Adl K; Mahmoud WR
RSC Adv; 2022 Apr; 12(20):12913-12931. PubMed ID: 35496328
[TBL] [Abstract][Full Text] [Related]
28. N-substituted hydroxynaphthalene imino-oxindole derivatives as new class of PI3-kinase inhibitor and breast cancer drug: Molecular validation and structure-activity relationship studies.
Rajesh Kumar M; Alagumuthu M; Violet Dhayabaran V
Chem Biol Drug Des; 2018 Jan; 91(1):277-284. PubMed ID: 28791774
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.
Rafiq M; Nazir Y; Ashraf Z; Rafique H; Afzal S; Mumtaz A; Hassan M; Ali A; Afzal K; Yousuf MR; Saleem M; Kotwica-Mojzych K; Mojzych M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-11. PubMed ID: 31456445
[TBL] [Abstract][Full Text] [Related]
30. 4-Aminocoumarin based Aroylthioureas as Potential Jack Bean Urease Inhibitors; Synthesis, Enzyme Inhibitory Kinetics and Docking Studies.
Fattah TA; Saeed A; Ashraf Z; Abbas Q; Channar PA; Larik FA; Hassan M
Med Chem; 2020; 16(2):229-243. PubMed ID: 31309895
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
32. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel C-2 symmetric Bis-Azo-Azamethine molecules as competitive inhibitors of mushroom tyrosinase and free radical scavengers: synthesis, kinetics, and molecular docking studies.
Saeed A; Ahmed A; Ali Channar P; Shabir G; Hassan A; Zia-Ur-Rehman ; Abbas Q; Hassan M; Raza H; Seo SY; El-Seedi HR
J Biomol Struct Dyn; 2022 Jul; 40(10):4419-4428. PubMed ID: 33342351
[TBL] [Abstract][Full Text] [Related]
34. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
35. High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.
Kumar M; Lowery R; Kumar V
SLAS Discov; 2020 Mar; 25(3):320-326. PubMed ID: 31868071
[TBL] [Abstract][Full Text] [Related]
36. Identification and Expression Analysis of CD73 Inhibitors in Cervical Cancer.
Iqbal J; Basharat A; Bano S; Abid SMA; Pelletier J; Sévigny J
Med Chem; 2021; 17(8):866-874. PubMed ID: 32981507
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
Beatty JW; Lindsey EA; Thomas-Tran R; Debien L; Mandal D; Jeffrey JL; Tran AT; Fournier J; Jacob SD; Yan X; Drew SL; Ginn E; Chen A; Pham AT; Zhao S; Jin L; Young SW; Walker NP; Leleti MR; Moschütz S; Sträter N; Powers JP; Lawson KV
J Med Chem; 2020 Apr; 63(8):3935-3955. PubMed ID: 32212732
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, Cytotoxic, and Antibacterial Evaluation of Quinazolinone Derivatives with Substituted Amino Moiety.
Zhan X; Xu Y; Qi Q; Wang Y; Shi H; Mao Z
Chem Biodivers; 2018 Mar; 15(3):e1700513. PubMed ID: 29333734
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor.
Almarsoomi T; Osmaniye D; Sağlık BN; Levent S; Ghani U; Özkay Y; Kaplancıklı ZA
J Mol Recognit; 2023 Jul; 36(7):e3025. PubMed ID: 37191245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
